与卡纳米辛,阿米卡辛,卡普雷米辛和贝达奎林相关的不良反应 - 一个VigiAccessTM研究
Lisa Singh1, Varsha Bangalee1, Serisha Ramasir1
1School of Health Science, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal.
African health sciences
|August 14, 2025
概括
随着时间的推移,多药耐药结核病 (MDR-TB) 治疗中的卡纳米,卡普雷米,阿米卡和贝达奎林的不良药物反应增加了. VigiAccessTM数据突出了特定的不良影响,有助于提高MDR-TB治疗的认识和未来的研究.
科学领域:
- 药物监督 药物监督 药物监督
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
背景情况:
- 耐多药结核病 (MDR-TB) 是一个重大的全球卫生挑战.
- 多抗药性结核病治疗涉及复杂的多药疗法,对特定药物不良反应 (ADR) 的证据有限.
研究的目的:
- 在MDR-TB患者中调查和比较报道的amycin,capreomycin,amicacin和bedaquiline的特定副作用.
- 分析与这些关键的MDR-TB药物相关的不良反应的趋势.
主要方法:
- 使用了来自公共VigiAccessTM数据库的二次数据.
- 对特定的MDR-TB药物报告的12个月的ADR数据进行了分析.
主要成果:
- 卡纳米辛显示增加了包括低音敏度,聋,耳,吐,恶心和腹在内的副作用.
- 卡普雷俄米辛的使用与增加的喘息和缺音症有关.
- 阿米卡辛的不良反应包括皮疹,和死亡率;贝达奎林与延长QT间隔,恶心,吐和腹有关.
结论:
- 干amycin,capreomycin,amicacin和bedaquiline与许多特定的不良影响有关.
- 这些特定不良反应的发生率在研究期间增加.
- VigiAccessTM作为一个有价值的平台,用于报告和提高人们对MDR-TB治疗相关的不良反应的认识,支持进一步的研究.
更多相关视频
相关概念视频
Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993
Antimicrobial Effectiveness
157
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
157
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Local Anesthetics: Adverse Effects
492
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
492
Antiepileptic Drugs: Potassium Channel Activators
276
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
276
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


